Dissertation > Excellent graduate degree dissertation topics show

Study of HMGB1on the Differentiation and Apoptosis of Leukemic Cells and Effects of Key Mechanism

Author: ZhangWen
Tutor: JiangGuoSheng
School: Jinan University
Course: Immunology
Keywords: High mobility group protein1 Leukemia All-trans retinoic acid arsenic trioxide acute promyelocytic leukemia
CLC: R733.7
Type: Master's thesis
Year: 2013
Downloads: 10
Quote: 0
Read: Download Dissertation


BackgroundLeukemia is one of the most common malignant tumors in China. It is ahematopoietic stem cell malignant cloning disease that serious threaten to childrenand young adults survival. Therefore, to reveal the pathogenesis of leukemia, lookingfor new targets for therapeutic intervention, has very important significance forprevention and treatment of leukemia.The academic circles agree that the occurrenceof leukemia is result of multiple factors and mechanisms (including proliferation,apoptosis, differentiation defect hindered), which involves the activation of oncogeneand the inactivation of tumor suppressor gene. Among them, induction differentiationtherapy of leukemia is the application of certain chemicals that reversal of immatureand malignant cells to normal cells.High mobility group protein1is a relatively small protein of215amino acidresidues. Named because of the high migration speed in polyacrylamide gelelectrophoresis. The protein molecular weight is about29kD. In the nucleus, HMGB1is a nonhistone DNA-binding protein and serves as a structural component to facilitatethe assembly of nucleoprotein complexes. Extracellular HMGB1is an importantpro-inflammatory mediator and chemotactic factor, involved in the pathogenesis ofinfectious diseases. Development of HMGB1involved in cancer is complex,cytosolic/nuclear and extracellular HMGB1with tumor occurrence, development,metastasis and chemotherapy response are closely related. HMGB1is highlyexpressed in a variety of solid tumors, including malignant melanoma, colon cancer,prostate cancer, pancreatic cancer, breast cancer. It is more important that the invasion and metastasis of HMGB1is correlated with tumor. Although the research describedabove, but the role of HMGB1in leukemia is not clear.ObjectiveThis study intends to establish the expression of HMGB1spectrum in differenttypes of leukemia. By detecting the expression of HMGB1in the differentiationinduced model to analyze its correlation with leukemia. To explore the biologicaleffect of HMGB1in the differentiation of leukemia cells. To elucidate the possiblemechanism and the structural basis of HMGB1mediated differentiation of leukemiacells. Open up a new field for the study of cell differentiation. Provide ideas andexperimental new clues for leukemia treatment.MethodsIt has trained nine different types of leukemia cells to the logarithmic growthphase. By reverse transcription polymerase chain reaction (RT-RCR) and Western blotmethod to detect the expression of HMGB1in the level of mRNA and protein in ninehuman leukemia cells. By positioning the immunohistochemistry qualitative andquantitative detection of HMGB1in clinical specimens in the expression of variousleukemia. The logarithmic growth phase of acute promyelocytic leukemia cells(HL-60) induced differentiation model, according to the different drugs into normalcontrol group, all trans retinoic acid (ATRA) and arsenic trioxide (As2O3) group, toobserve the morphology of HL-60cells by Wright-Gimesa staining, cell proliferationwas measured by CCK8assay, cell cycle and the expression of detection of HL-60cell differentiation antigen CD11b by flow cytometry, the detection of RT-PCR andWestern blot methods of acute promyelocytic leukemia (HL-60) with all trans retinoicacid (ATRA) and arsenic trioxide (As2O3) HMGB1expression at mRNA and proteinlevel of24h,48h,72h,96h after induction. We built the expression of the small-signalmodel of HMGB1interference.ResultsEffect of1μmol/L ATRA and1μmol/L As2O3in HL-60cells can significantlyinhibit the proliferation, differentiation into mature myeloid cells were observed under inverted microscope cell morphology, expression of cell surface differentiationantigen CD11b flow cytometry was significantly increased (p<0.05), Annexin V/PIdouble staining was used to detect apoptosis of As2O3group showed0to4days theapoptosis rate from3.35±0.31%to25.75±8.39%elevated (p<0.05), RT-PCR andWestern blot results showed that HMGB1had high expression in various types ofleukemia, including acute promyelocytic leukemia cells in the highest expression,clinical bone marrow pathology immunohistochemical results also support the aboveconclusion HMGB1is mainly expressed in the nucleus, and in HL-60cells byall-trans retinoic acid (ATRA) induced to granulocyte differentiation at the same time,HMGB1was expressed at mRNA and protein level decreased, the difference wasstatistically significant (p<0.05), HL-60cells (As2O3) induced by arsenic trioxide inthe myeloid differentiation, apoptosis appeared as part of a cell, HMGB1in mRNAthe expression with time increased, the difference was statistically significant(p<0.05). Small interference model establishment failure.ConclusionsThe HMGB1expression is higher in various leukemia cells, in acutepromyelocytic leukemia (M3) of high expression of HMGB1cells, and expressedmainly in the nucleus. With all-trans retinoic acid treatment time prolongs, theexpression of HMGB1in acute promyelocytic leukemia cells gradually decreased, thelevel of transcription and translation, a downward trend. Negatively correlated withdifferentiation degree and the degree of HMGB1expression in HL-60cells. With theeffect of arsenic trioxide time increasing, the expression of HMGB1in acutepromyelocytic leukemia cells gradually increased, the level of transcription andtranslation, is upward trend. Related expression level of HMGB1and HL-60apoptosis positive.

Related Dissertations

  1. The Research of the Expression Level of Hexokinasel1 in the Chronic Phase and Blastic Phase of Patients with Chronic Myeloid Leukemia,R733.7
  2. Induction of Apoptosis by d-limonene is Mediated by Mitochondrial Death Pathway in Human Leukemia Cells,R733.7
  3. Effects of Arsenic Trioxide on the Proliferation, Apoptosis and the Expression of BMP-2 Gene in Osteoblasts Cultured in Vitro,R363
  4. Establishment of Stable Subline of K562 Cells Overexpressing HMGB1 Protein.,R733.7
  5. The Expression and Correlation Analysis of MT1A and MT1X in Patients with Acute Leukemia,R733.71
  6. Study on the in Vitro Effect of Zinc on the Growth of Murine Embryonic Palatal,R782.2
  7. Suppression Subtractive Hybridization multidrug resistance gene,R733.7
  8. Children with acute leukemia also prototype folate carrier gene polymorphism,R733.71
  9. 866 cases of secondary leukemia karyotype analysis,R733.7
  10. The Characteristics of Cytogenetics and Molecular Genetics in T Cell Acute Lymphoblastic Leukemia,R733.7
  11. Analysis of the Correlation Between Serum Thymidine Kinase1 and Acute Myeloid Leukemia,R733.71
  12. Genetic Study of IL-15 in All and Generation of Anti-IL-1α Antibody and Related Study of IL-1α,R733.71
  13. The Singnificance of the Expression of The TPMT in Childhood Acut Lymphoblastic Leukemia,R733.71
  14. RNAi Down-regulated Thioredoxin Expression Sensitizes U251 Cells to Arsenic Trioxide-induced Apoptosis,R739.4
  15. Effects of Simvastatin on WT1/hDMP1 Gene Expression Profiles of Human Acute Myeloid Leukemia Cells Lines,R733.71
  16. Effect of GCS on Expression of MDR1mRNA and P-gp Function in K562/AO2 Cell Line,R733.7
  17. The Clinical Significance and Correlation Study of AML1-ETO9a Isoform in AML-M2 with T(8;21),R733.7
  18. Analysis of Myeloid Associated Antigens and JAK1 Gene Mutations in T-ALL,R733.7
  19. Generation of Anti-human ppGalNAc-T2 Monoclonal Antibody and the Effect of ppGalNAc-T2 Gene Expression Mediated by Lentivirus on the Malignant Phenotype of Leukemia Cell Line,R733.7
  20. The Clinical Significance of WT1 Gene Expression and WT1 Gene Mutation in Acute Myeloid Leukemia of Children,R733.71
  21. Impact of TET2 Mutations and An TET2 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia,R733.71

CLC: > Medicine, health > Oncology > Hematopoietic and lymphoid neoplasms > Leukemia
© 2012 www.DissertationTopic.Net  Mobile